Your Doctor Said No to GLP-1: Here's What to Do Next

You worked up the courage to ask your doctor about GLP-1 medication — and they said no. Maybe they cited your BMI. Maybe they said it's "not appropriate" without much explanation. Maybe they seemed dismissive of the whole category.

That conversation is frustrating, but it's not necessarily the end of the road. Here's what might be behind that "no," when to push back, and what your alternatives look like.

Common Reasons Doctors Say No

1. BMI Doesn't Meet the Threshold

FDA-approved GLP-1 medications for weight loss (Wegovy, Zepbound) require a BMI of 30 or greater, or 27 or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, high cholesterol, or sleep apnea. If your BMI falls below these thresholds, most providers — in-person or telehealth — won't prescribe.

What to do: Make sure your doctor factored in comorbidities. A BMI of 28 with controlled hypertension still qualifies. If you weren't asked about comorbidities, bring documentation at a follow-up visit.

2. You Have a Contraindication

There are legitimate medical reasons a doctor would refuse to prescribe. These include a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia type 2 (MEN2), a history of pancreatitis, or pregnancy. These are hard contraindications where "no" is the right answer.

3. Your Doctor Isn't Comfortable With GLP-1s

Many primary care physicians haven't received specific training in obesity medicine or GLP-1 prescribing. Some are cautious about a medication class that's received enormous media attention. Others may have philosophical objections to pharmacological weight loss treatment. This isn't a reflection of your eligibility — it's a reflection of their practice preferences.

4. Insurance Won't Cover It

Some doctors won't prescribe medications they know insurance will deny, to avoid creating a cycle of prior authorization appeals. This is well-intentioned but potentially limiting, especially since compounded alternatives and manufacturer direct-to-consumer pricing now make GLP-1s accessible without insurance.

5. They Want You to Try Lifestyle Changes First

Some providers follow a "step therapy" approach — requiring documented evidence of diet and exercise attempts before prescribing medication. While this makes sense for some patients, current clinical guidelines from the American Association of Clinical Endocrinology (AACE) recognize that GLP-1 medications can be appropriate as a first-line treatment for patients with obesity, not just as a last resort.

When to Get a Second Opinion

Consider seeking a second opinion if any of these apply:

• Your doctor didn't explain why you were denied, or gave vague reasons
• They didn't ask about comorbidities or check your complete medical history
• They seemed unfamiliar with current GLP-1 prescribing guidelines
• Their objection was philosophical ("you just need to eat less") rather than medical
• They cited insurance denial as the reason but didn't discuss cash-pay alternatives

A board-certified obesity medicine specialist or endocrinologist is often more experienced with these medications and more current on clinical guidelines.

Telehealth as an Alternative Path

Telehealth GLP-1 providers have become a mainstream option for patients who either can't access in-person prescribers or whose local doctors won't prescribe. The best telehealth platforms use licensed physicians, conduct thorough medical screenings, and provide ongoing monitoring.

What to Bring to Your Next Conversation

Whether you're going back to your current doctor or trying a new provider, prepare these things:

1. Your BMI calculation and documented comorbidities. Bring recent lab work if you have it.
2. A record of previous weight loss attempts. Document what you've tried and for how long — this addresses the "lifestyle first" objection.
3. Specific questions about why you were denied. "Can you help me understand which specific medical concern led to that decision?"
4. Current clinical guidelines. The AACE and Endocrine Society both support GLP-1 medications as appropriate treatments for obesity.

A good doctor will welcome a patient who comes prepared. If they respond defensively to informed questions, that tells you something about whether they're the right provider for this part of your care.